Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: Faint; Vomited; Stomach cramps; patient was exposed to the medicine second-trimester (13-28 weeks); This is a spontaneous report from a contactable consumer received from the Regulatory Agency (RA). The regulatory authority report number is GB-MHRA-WEBCOVID-202106051020264080-I3EW9 and Safety Report Unique Identifier GB-MHRA-ADR 25425444. A 34-year-old female patient received first dose of bnt162b2 (Pfizer-BioNTtech COVID-19 VACCINE), via an unspecified route of administration on 04Jun2021 (Batch/Lot number: Unknown), at the age of 34 years, as 1st dose, single for COVID-19 immunization. Medical history included ulcerative colitis, ongoing pregnancy, immunodeficiency and folic acid supplementation. Patient has not had symptoms associated with COVID-19. Not had a COVID-19 test. Patient is not enrolled in clinical trial. Patient is not currently breastfeeding. Concomitant medications included folic acid taken for folic acid supplementation. On 05Jun2021, the patient experienced faint, vomited and stomach cramps. On 04Jun2021, the patient was exposed to the medicine second-trimester (13-28 weeks). Patient has not tested positive for COVID-19 since having the vaccine. The case is serious (medically significant). The outcome of the event faint was recovered on an unspecified date; events stomach cramps and vomited outcome was recovering. The outcome for patient was exposed to the medicine second-trimester (13-28 weeks) was unknown. No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166